⌘K
t
On 6 February 2026, Fortis Frontier PLC purchased 85,000 of its own ordinary shares at 8.0p per share, representing approximately 0.16% of its issued share capital. Following the planned cancellation of these shares, the Company's total ordinary shares in issue will be 51,600,827. Fortis Frontier PLC also announced the appointment of Singer Capital Markets as its Corporate Broker with immediate effect, while Spark Advisory remains as its Nominated Adviser.
| Date | 9 Feb 2026 |
| Time | 07:00:10 |
| Category | Miscellaneous |
| ID | 1469S |
Fortis Frontier PLC
("Fortis Frontier" or the "Company")
Transaction in Own Shares and Total Voting Rights
Appointment of Corporate Broker
Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly MyHealthChecked PLC), announces that on 6 February 2026, pursuant to the authority approved by shareholders at the Company's Annual General Meeting of 31 July 2025, the Company purchased 85,000 ordinary shares of 1.5 pence each ("Ordinary Shares") at a price of 8.0p per share, representing approximately 0.16% of the Company's issued share capital.
Total Voting Rights
The Company intends that the purchased Ordinary Shares will be cancelled in due course. Following cancellation of the purchased Ordinary Shares, the Company's total number of Ordinary Shares in issue shall be 51,600,827 Ordinary Shares.
The above figure of 51,600,827 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The Company also announces the appointment of Singer Capital Markets as the Company's Corporate Broker with immediate effect following the transfer of Dowgate Capital's corporate broking, advisory and research team to Singer Capital Markets. Spark Advisory remains as the Company's Nominated Adviser.
For further information contact:
|
Fortis Frontier PLC |
||
|
Adam Reynolds, Executive Chairman |
via Walbrook PR |
|
|
|
|
|
|
SPARK Advisory Partners Limited (NOMAD) |
Tel: +44 (0)20 3368 3550 |
|
|
Neil Baldwin / Dillon Wall |
|
|
|
|
|
|
|
Singer Capital Markets (Broker) |
Tel: +44 (0)20 7496 3000 |
|
|
James Serjeant / Russell Cook / Amber Higgs |
|
|
|
|
|
|
|
Walbrook PR Ltd (Media & IR) |
Tel: +44 (0)20 7933 8780 or fortisfrontier@walbrookpr.com |
|
|
Paul McManus / Alice Woodings |
Mob: +44 (0)7980 541 893 / +44(0)7407 804 654 |
|
About Fortis Frontier PLC
On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell, as defined in the AIM Rules for Companies. On the same day the Company changed its name to Fortis Frontier PLC. The Board is now carefully considering the strategic options available to it in order to maximise shareholder value.